AAAAAA
Results: 1-25/34
Authors:
Holdenrieder, S
Stieber, P
Bodenmuller, H
Fertig, G
Furst, H
Schmeller, N
Untch, M
Seidel, D
Citation: S. Holdenrieder et al., Nucleosomes in serum as a marker for cell death, CLIN CH L M, 39(7), 2001, pp. 596-605
Authors:
Konecny, G
Untch, M
Arboleda, J
Wilson, C
Kahlert, S
Boettcher, B
Felber, M
Beryt, M
Lude, S
Hepp, H
Slamon, D
Pegram, M
Citation: G. Konecny et al., HER-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer, CLIN CANC R, 7(8), 2001, pp. 2448-2457
Authors:
Konecny, G
Untch, M
Pihan, A
Kimmig, R
Gropp, M
Stieber, P
Hepp, H
Slamon, D
Pegram, M
Citation: G. Konecny et al., Association of urokinase-type plasminogen activator and its inhibitor withdisease progression and prognosis in ovarian cancer, CLIN CANC R, 7(6), 2001, pp. 1743-1749
Authors:
Untch, M
Von Koch, F
Crohns, C
Sobotta, K
Kahlert, S
Konecny, G
Hepp, H
Citation: M. Untch et al., Dose-dense and sequential strategies in adjuvant breast cancer therapy, ONCOLOGY-NY, 15(5), 2001, pp. 14-20
Authors:
Lebeau, A
Deimling, D
Kaltz, C
Sendelhofert, A
Iff, A
Luthardt, B
Untch, M
Lohrs, U
Citation: A. Lebeau et al., HER-2/neu analysis in archival tissue samples of human breast cancer: Comparison of immunohistochemistry and fluorescence in situ hybridization, J CL ONCOL, 19(2), 2001, pp. 354-363
Authors:
Tiling, R
Linke, R
Untch, M
Richter, A
Fieber, S
Brinkbaumer, K
Tatsch, K
Hahn, K
Citation: R. Tiling et al., F-18-FDG PET and Tc-99m-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study, EUR J NUCL, 28(6), 2001, pp. 711-720
Authors:
Konecny, G
Fritz, M
Untch, M
Lebeau, A
Felber, M
Lude, S
Beryt, M
Hepp, H
Slamon, D
Pegram, M
Citation: G. Konecny et al., HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer, BREAST CANC, 69(1), 2001, pp. 53-63
Authors:
Konecny, G
Untch, M
Slamon, D
Beryt, M
Kahlert, S
Felber, M
Langer, E
Lude, S
Hepp, H
Pegram, M
Citation: G. Konecny et al., Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples, BREAST CANC, 67(3), 2001, pp. 223-233
Authors:
Holdenrieder, S
Stieber, P
Bodenmuller, H
Busch, M
Fertig, G
Furst, H
Schalhorn, A
Schmeller, N
Untch, M
Seidel, D
Citation: S. Holdenrieder et al., Nucleosomes in serum of patients with benign and malignant diseases. (vol 95, pg 114, 2001), INT J CANC, 95(6), 2001, pp. 398-398
Authors:
Holdenrieder, S
Stieber, P
Bodenmuller, H
Busch, M
Fertig, G
Furst, H
Schalhorn, A
Schmeller, N
Untch, M
Seidel, D
Citation: S. Holdenrieder et al., Nucleosomes in serum of patients with benign and malignant diseases, INT J CANC, 95(2), 2001, pp. 114-120
Authors:
Stieber, P
Molina, R
Chan, DW
Fritsche, HA
Beyrau, R
Bonfrer, JMG
Filella, X
Gornet, TG
Hoff, T
Jager, W
van Kamp, GJ
Nagel, D
Peisker, K
Sokoll, LJ
Troalen, F
Untch, M
Domke, I
Citation: P. Stieber et al., Evaluation of the analytical and clinical performance of the Elecsys (R) CA 15-3 immunoassay, CLIN CHEM, 47(12), 2001, pp. 2162-2164
Authors:
Konecny, G
Frank, M
Kahlert, S
Untch, M
Hepp, H
Citation: G. Konecny et al., Retrospective analysis of dose intensity of epirubicin in breast cancer, GYNAKOL GEB, 40(3-4), 2000, pp. 145-152
Authors:
Prechtl, A
Harbeck, N
Thomssen, C
Meisner, C
Braun, M
Untch, M
Wieland, M
Lisboa, B
Cufer, T
Graeff, H
Selbmann, K
Schmitt, M
Janicke, F
Citation: A. Prechtl et al., Tumor-biological factors uPA and PAI-1 as stratification criteria of a multicenter adjuvant chemotherapy trial in node-negative breast cancer, INT J B MAR, 15(1), 2000, pp. 73-78
Authors:
Untch, M
Crohns, C
Kahlert, S
Hepp, H
Citation: M. Untch et al., Anthracyclines and herceptin (R): New treatment option for patients with metastatic breast cancer, ONKOLOGIE, 23, 2000, pp. 15-19
Authors:
Konecny, G
Crohns, C
Pegram, M
Felber, M
Lude, S
Kurbacher, C
Cree, IA
Hepp, H
Untch, M
Citation: G. Konecny et al., Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer, GYNECOL ONC, 77(2), 2000, pp. 258-263
Authors:
Sittek, H
Linsmeier, E
Perlet, C
Schneider, P
Baudrexel, C
Untch, M
Reiser, M
Citation: H. Sittek et al., Preoperative localization and biopsy of non-palpable breast lesions with aspecial localization device on the Magnetom Open, RADIOLOGE, 40(11), 2000, pp. 1098-1105
Authors:
Hillemanns, P
Untch, M
Dannecker, C
Baumgartner, R
Stepp, H
Diebold, J
Weingandt, H
Prove, F
Korell, M
Citation: P. Hillemanns et al., Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid, INT J CANC, 85(5), 2000, pp. 649-653
Authors:
Konecny, G
Pegram, M
Untch, M
Thomssen, C
Janicke, F
Hepp, H
Slamon, DJ
Citation: G. Konecny et al., HER-2/neu as a predictive marker in breast cancer, GEBURTSH FR, 60(12), 2000, pp. 609-619
Authors:
Ebeling, FC
Schmitt, UM
Untch, M
Nagel, D
Fateh-Moghadam, A
Stieber, P
Seidel, D
Citation: Fc. Ebeling et al., Tumour markers CEA and CA 15-3 as prognostic factors in breast cancer - Univariate and multivariate analysis, ANTICANC R, 19(4A), 1999, pp. 2545-2550
Authors:
Backe, J
Hofferbert, S
Skawran, B
Dork, T
Stuhrmann, M
Karstens, JH
Untch, M
Meindl, A
Burgemeister, R
Chang-Claude, J
Weber, BHF
Citation: J. Backe et al., Frequency of BRCA1 mutation 5382insC in German breast cancer patients, GYNECOL ONC, 72(3), 1999, pp. 402-406
Authors:
Hillemanns, P
Untch, M
Prove, F
Baumgartner, R
Hillemanns, M
Korell, M
Citation: P. Hillemanns et al., Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid, OBSTET GYN, 93(1), 1999, pp. 71-74
Authors:
Hillemanns, P
Korell, M
Schmitt-Sody, M
Baumgartner, R
Beyer, W
Kimmig, R
Untch, M
Hepp, H
Citation: P. Hillemanns et al., Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5-aminolevulinic acid, INT J CANC, 81(1), 1999, pp. 34-38
Authors:
Hepp, H
Untch, M
Bender, HG
Nitz, U
Citation: H. Hepp et al., Metastatic breast cancer - Part 2, GYNAKOLOGE, 32(9), 1999, pp. 665-665
Authors:
Stieber, P
Untch, M
Sauer, H
Citation: P. Stieber et al., Role of tumor markers in breast cancer, GYNAKOLOGE, 32(9), 1999, pp. 695-704
Authors:
Crohns, C
Konecny, G
Blokh, E
Kurbacher, C
Cree, I
Untch, M
Citation: C. Crohns et al., Is there a role for pretherapeutic chemosensitivity testing in breast cance?, GYNAKOLOGE, 32(9), 1999, pp. 705-709